| Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1 C Roux, SM Jafari, R Shinde, G Duncan, DW Cescon, J Silvester, MF Chu, ... Proceedings of the National Academy of Sciences 116 (10), 4326-4335, 2019 | 156 | 2019 |
| AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer SP Kubli, C Bassi, C Roux, A Wakeham, C Göbl, W Zhou, SM Jafari, ... Proceedings of the National Academy of Sciences 116 (9), 3604-3613, 2019 | 100 | 2019 |
| Subjugation of TGFβ signaling by human papilloma virus in head and neck squamous cell carcinoma shifts DNA repair from homologous recombination to alternative end joining Q Liu, L Ma, T Jones, L Palomero, MA Pujana, H Martinez-Ruiz, PK Ha, ... Clinical Cancer Research 24 (23), 6001-6014, 2018 | 92 | 2018 |
| NSD2 is a conserved driver of metastatic prostate cancer progression A Aytes, A Giacobbe, A Mitrofanova, K Ruggero, J Cyrta, J Arriaga, ... Nature communications 9 (1), 5201, 2018 | 81 | 2018 |
| New perspectives on screening and early detection of endometrial cancer L Costas, J Frias‐Gomez, M Guardiola, Y Benavente, M Pineda, ... International journal of cancer 145 (12), 3194-3206, 2019 | 62 | 2019 |
| AURKA overexpression is driven by FOXM1 and MAPK/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy JA Puig-Butille, A Vinyals, JR Ferreres, P Aguilera, E Cabré, G Tell-Marti, ... Journal of Investigative Dermatology 137 (6), 1297-1310, 2017 | 47 | 2017 |
| RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors PS Patel, KJ Abraham, KKN Guturi, MJ Halaby, Z Khan, L Palomero, B Ho, ... The Journal of clinical investigation 131 (3), 2021 | 46 | 2021 |
| Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors Á Lahiguera, P Hyroššová, A Figueras, D Garzón, R Moreno, ... EMBO molecular medicine 12 (6), e11217, 2020 | 46 | 2020 |
| Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ... Oncogene 36 (19), 2737-2749, 2017 | 41 | 2017 |
| Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis L Li, KKN Guturi, B Gautreau, PS Patel, A Saad, M Morii, F Mateo, ... The Journal of clinical investigation 128 (10), 4525-4542, 2018 | 38 | 2018 |
| Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types Q Liu, L Palomero, J Moore, I Guix, R Espín, A Aytés, JH Mao, ... Science translational medicine 13 (580), eabc4465, 2021 | 37 | 2021 |
| Mammary epithelial cells have lineage-rooted metabolic identities MJ Mahendralingam, H Kim, CW McCloskey, K Aliar, AE Casey, ... Nature Metabolism 3 (5), 665-681, 2021 | 33 | 2021 |
| Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population A Amell, A Roso-Llorach, L Palomero, D Cuadras, I Galván-Femenía, ... Scientific reports 8 (1), 15970, 2018 | 25 | 2018 |
| Modification of BRCA1-associated breast cancer risk by HMMR overexpression F Mateo, Z He, L Mei, GR de Garibay, C Herranz, N García, A Lorentzian, ... Nature communications 13 (1), 1895, 2022 | 23 | 2022 |
| Antitumor effects of anti-semaphorin 4D antibody unravel a novel proinvasive mechanism of vascular-targeting agents I Zuazo-Gaztelu, M Pŕez-Ribes, P Carrasco, L Martín, A Soler, ... Cancer research 79 (20), 5328-5341, 2019 | 23 | 2019 |
| Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients V Ruiz de Porras, S Bystrup, S Cabrero-de Las Heras, E Musulén, ... Cancers 11 (10), 1540, 2019 | 21 | 2019 |
| Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity J Gomez-Miragaya, A Diaz-Navarro, R Tonda, S Beltran, L Palomero, ... Cancer research 79 (16), 4258-4270, 2019 | 20 | 2019 |
| Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment VR de Porras, XC Wang, L Palomero, M Marin-Aguilera, C Solé-Blanch, ... European urology 79 (6), 722-733, 2021 | 19 | 2021 |
| NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity N Haider, P Dutt, B van de Kooij, J Ho, L Palomero, MA Pujana, M Yaffe, ... Oncogene 39 (30), 5252-5266, 2020 | 16 | 2020 |
| Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance G Ruiz de Garibay, F Mateo, A Stradella, R Valdes-Mas, L Palomero, ... Disease models & mechanisms 11 (5), dmm032292, 2018 | 16 | 2018 |
Katia RuggeroVerified email at idibell.cat
Katia RuggeroVerified email at idibell.cat